Hybrid closed-loop therapy significantly improved maternal glycemic control during pregnancy in people with type 1 diabetes, providing a clinical advantage beyond that achieved with continuous glucose monitoring (CGM) and insulin-pump therapy, shows the AiDAPT randomized controlled trial.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045